Systematic review with meta-analysis of mid-regional pro-adrenomedullin (MR-proadm) as a prognostic marker in Covid-19-hospitalized patientsarticle Published on 2023-01-062024-09-05 Journal: Annals of medicine [Category] update2024, [키워드] COVID-19 marker mid-regional pro-adrenomedullin MR-proADM SARS-CoV-2 [DOI] 10.1080/07853890.2022.2162116 PMC 바로가기 [Article Type] article
Identification of COVID-19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid-regional pro-adrenomedullinObservational Study Published on 2022-08-282022-10-05 Journal: Respiratory Research [Category] SARS, 바이오마커, 임상, [키워드] age Analysis assessment Bacterial infections Classifier collected Combination COVID-19 patient CRP death demographics Department discharge Emergency emergency department Europe European examined failure hospital Hospital admission hospitalisation identification identify IMPROVE in viral increased risk infected with SARS-CoV-2 Infection Inflammatory biomarker International LDH mid-regional pro-adrenomedullin Mortality MR-proADM multicenter multicentre Organ failure outcome Patient patients performed presenting previous study primary endpoint prognostic Prognostic factor random Retrospective analysis risk RT-qPCR Safe SARS-CoV-2 SARS-COV-2 infection secondary care Sepsis Septic shock SOFA SOFA score the patient Treatment utility was performed [DOI] 10.1186/s12931-022-02151-1 PMC 바로가기 [Article Type] Observational Study
Prognostic Value of Mid-Region Proadrenomedullin and In Vitro Interferon Gamma Production for In-Hospital Mortality in Patients with COVID-19 Pneumonia and Respiratory Failure: An Observational Prospective StudyCOVID-19 폐렴 및 호흡부전 환자의 병원 내 사망률에 대한 중간 지역 Proadrenomedullin 및 체외 인터페론 감마 생산의 예후적 가치: 관찰적 전향적 연구Observational Study Published on 2022-07-302022-09-11 Journal: Viruses [Category] MERS, 바이오마커, 임상, [키워드] 95%CI Admission Adult patients adverse outcome adverse outcomes AUROC best Biomarker cause characterized Coagulopathy Comorbidity coronavirus coronavirus disease COVID-19 COVID-19 pneumonia COVID-19 vaccination cut-off cut-off point Deceased dysregulation endothelial damage enrolled Enrollment Evidence evidence of females Gamma groups Hospital mortality Hospitalization IFNγ immune dysregulation Immune suppression Immunocompromised patients in vitro in-hospital mortality infection risk interferon interferon gamma median age mid-region proadrenomedullin MONITOR Mortality MR-proADM Negative predictive value Non-COVID-19 observational study PaO2:FiO2 Patient patients with COVID-19 Pneumonia predict Predictive value predictive value) Production Prognostic factor Prospective quantiferon monitor. radiologic respiratory Respiratory failure SARS-CoV-2 sensitivity significantly specificity subset survivor the median value were measured with COVID-19 with infection [DOI] 10.3390/v14081683 PMC 바로가기 [Article Type] Observational Study
Mid-regional proadrenomedullin, C-terminal proendothelin-1 values, and disease course are not different in critically ill SARS-CoV-2 pneumonia patients with obesity Research Published on 2022-07-152022-10-05 Journal: International journal of obesity (2005) [Category] COVID19(2023년), SARS, 바이오마커, 임상, [키워드] 28-day mortality acute respiratory syndrome Admission affected baseline Blood BMI body mass index C-reactive protein C-terminal caused changed chronic inflammation Clinical outcome collected Concentration concentrations coronavirus Coronavirus disease 2019 Critically ill Critically ill patient CRP disease course higher risk ICU Inflammatory biomarker intensive care investigated marker mechanisms MR-proADM Netherland no significant difference not different obesity Observational cohort study outcome Patient patients with obesity PCT procalcitonin Result retrospective SARS-CoV-2 SARS-CoV-2 pneumonia significantly suggested the disease ventilator WBC [DOI] 10.1038/s41366-022-01184-2 [Article Type] Research
Prognostic value of copeptin and mid-regional proadrenomedullin in COVID-19-hospitalized patientsCOVID-19 입원 환자에서 코펩틴 및 중부 프로아드레노메둘린의 예후 가치Article Published on 2022-05-012022-09-11 Journal: European Journal of Clinical Investigation [Category] MERS, 바이오마커, [키워드] Acute kidney injury Admission AUROC Biomarkers Care complications copeptin coronavirus disease Coronavirus disease 2019 COVID-19 database death Diagnosis eligible endothelial function expressed hazard ratio help Hospital mortality identify In-hospital in-hospital complication in-hospital complications in-hospital mortality intensive care intensive care unit interquartile range marker median mid-regional proadrenomedullin Mortality MR-proADM non-survivor Non-survivors outcome outcomes Patient patients hospitalized Pneumonia predict predicted predictive power primary endpoint Prognosis Receiver operator characteristic risk stratification secondary endpoint Secondary endpoints Sepsis Septic shock Stress survivor was increased were assessed with COVID-19 [DOI] 10.1111/eci.13753 PMC 바로가기 [Article Type] Article
Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients벤치에서 병상까지 사이토카인: 코로나19 환자에서 음성 결과의 위험을 조기에 평가하기 위한 확실한 바이오마커 패널을 확인하는 후향적 연구Observational Study Published on 2022-04-272022-09-11 Journal: International Journal of Molecular Sciences [Category] 바이오마커, 임상, [키워드] affected age anti-inflammatory response Bench best Biomarker Biomarkers C-reactive protein conducted correlations COVID-19 COVID-19 patient COVID-19 patients CRP cut-off cytokine Cytokines death Definite disease pathogenesis Endothelial dysfunction explain Extensive help Hospital admission Hospitalized identify IL-10 IL-1β IL-6 IL-8 immunoparalysis interferon interferon-γ interleukin interleukin 6 Intervention intubation IP10 majority marker mortality rate MR-proADM negative observational study orotracheal intubation outcome Panel Patient performed Predictive Predictive value proadrenomedullin Prognosis representing retrospective risk severe patients sIL2Rα. Stage statistical analysis synergy systemic inflammation tested TNFα variable worse prognosis [DOI] 10.3390/ijms23094830 PMC 바로가기 [Article Type] Observational Study
Mid-Regional Pro-Adrenomedullin, Methemoglobin and Carboxyhemoglobin as Prognosis Biomarkers in Critically Ill Patients with COVID-19: An Observational Prospective StudyCOVID-19를 가진 중환자 환자에서 예후 바이오 마커로서 중간 지역 프로 아드레노메드 룰린, 메트 메모 글로빈 및 카르복시 헤모글로빈 : 관찰 전향 적 연구Observational Study Published on 2021-12-062022-08-31 Journal: Viruses [Category] SARS, 바이오마커, 임상, [키워드] 30-Day mortality 95% CI an area Arterial thrombosis Biomarkers carboxyhemoglobin COHb Cohort consecutive patient COVID-19 patients Critically ill critically ill COVID-19 patients Critically ill patient critically ill patients cut-off elevated Follow-up higher risk Ill intubation likelihood ratio median MetHb methemoglobin mid-regional pro-adrenomedullin Mortality MR-pro-ADM MR-proADM orotracheal intubation outcome Patient patients died positive Potential biomarker Predictive Prospective required ROC Curve SARS-CoV-2 Sepsis thrombosis venous VTE with COVID-19 [DOI] 10.3390/v13122445 PMC 바로가기 [Article Type] Observational Study
Endothelium-associated biomarkers mid-regional proadrenomedullin and C-terminal proendothelin-1 have good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: A prospective cohort study내피 관련 바이오마커 mid-regional proadrenomedullin 및 C-terminal proendothelin-1은 SARS-CoV-2 폐렴 중환자에서 28일 사망률을 예측하는 우수한 능력을 가지고 있습니다. 전향적 코호트 연구Observational Study Published on 2021-12-012022-09-11 Journal: Journal of critical care [Category] SARS, 바이오마커, 임상, [키워드] 28-day mortality 95% CI acute respiratory syndrome acute respiratory syndrome coronavirus adjusted age AUC baseline Biomarker Biomarkers C-terminal collected coronavirus COVID-19 Critically ill Critically ill patient critically ill patients CT-proET-1 high accuracy identify investigated Mortality MR-proADM MR-proADM. multivariable Cox regression multivariable Cox regression model non-survivor Pneumonia predict predictor prospective cohort study prospective observational cohort remained respiratory ROC Curve ROC curves SARS-CoV-2 SARS-CoV-2 pneumonia Seven severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 significantly higher SOFA score [DOI] 10.1016/j.jcrc.2021.07.017 PMC 바로가기 [Article Type] Observational Study
Endothelial dysfunction and Mid-Regional proAdrenomedullin: What role in SARS-CoV-2 infected Patients?내피 기능 장애와 중부 프로아드레노메둘린: SARS-CoV-2 감염 환자에서 어떤 역할을 합니까?Article Published on 2021-12-012022-09-11 Journal: Clinica chimica acta; international journal of cli [Category] SARS, 바이오마커, 치료기술, [키워드] Admission adrenomedullin adverse event adverse events age C-reactive protein cell count clinically consecutive patient COVID-19 patient COVID-19 patients D-dimer death disease dysfunction EDTA endothelial damage Endothelial dysfunction Endothelitis Germany greater high risk highlight Hospitalization information intensive care unit Logistic Logistic regression material Mortality MR-proADM Multi-organ damage neutrophil neutrophil count Occurrence plasma sample plasma samples Pneumonia predictor procalcitonin Prognosis risk SARS-CoV-2 SARS-COV-2 infection Significant significant differences the patient Thermo Fisher Scientific three group three groups Treatment troponin I was measured [DOI] 10.1016/j.cca.2021.09.016 PMC 바로가기 [Article Type] Article
Role of MR-proADM in the risk stratification of COVID-19 patients assessed at the triage of the Emergency Department응급실 분류에서 평가된 COVID-19 환자의 위험 계층화에서 MR-proADM의 역할Research Letter Published on 2021-11-262022-09-11 Journal: Critical Care [Category] MERS, 바이오마커, [키워드] COVID-19 patient Department Emergency MR-proADM risk stratification role [DOI] 10.1186/s13054-021-03834-9 PMC 바로가기 [Article Type] Research Letter